These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 28258657)

  • 1. Intravesical liposome therapy for interstitial cystitis.
    Tyagi P; Kashyap M; Majima T; Kawamorita N; Yoshizawa T; Yoshimura N
    Int J Urol; 2017 Apr; 24(4):262-271. PubMed ID: 28258657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Intravesical Liposome-Based Nerve Growth Factor Antisense Therapy on Bladder Overactivity and Nociception in a Rat Model of Cystitis Induced by Hydrogen Peroxide.
    Majima T; Tyagi P; Dogishi K; Kashyap M; Funahashi Y; Gotoh M; Chancellor MB; Yoshimura N
    Hum Gene Ther; 2017 Jul; 28(7):598-609. PubMed ID: 28446032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Prospective, Multicenter, Double-Blind, Randomized Trial of Bladder Instillation of Liposome Formulation OnabotulinumtoxinA for Interstitial Cystitis/Bladder Pain Syndrome.
    Chuang YC; Kuo HC
    J Urol; 2017 Aug; 198(2):376-382. PubMed ID: 28202358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in intravesical therapy for urinary tract disorders.
    Tyagi P; Kashyap M; Hensley H; Yoshimura N
    Expert Opin Drug Deliv; 2016; 13(1):71-84. PubMed ID: 26479968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Noninvasive Intravesical Instillation of Onabotulinum Toxin-A for Overactive Bladder and Interstitial Cystitis/Bladder Pain Syndrome: Systematic Review and Meta-analysis.
    Lee HY; Doo SW; Yang WJ; Song YS; Sun HY; Nho EJ; Lee B; Kim JH
    Urology; 2019 Mar; 125():50-57. PubMed ID: 30552935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravesical liposome versus oral pentosan polysulfate for interstitial cystitis/painful bladder syndrome.
    Chuang YC; Lee WC; Lee WC; Chiang PH
    J Urol; 2009 Oct; 182(4):1393-400. PubMed ID: 19683290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Applications of Non-Invasive Intravesical Botulinum Toxin a Delivery in the Treatment of Functional Bladder Disorders.
    Jhang JF; Kuo HC
    Toxins (Basel); 2021 May; 13(5):. PubMed ID: 34069951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential Effect of Liposomes and Liposome-Encapsulated Botulinum Toxin and Tacrolimus in the Treatment of Bladder Dysfunction.
    Janicki JJ; Chancellor MB; Kaufman J; Gruber MA; Chancellor DD
    Toxins (Basel); 2016 Mar; 8(3):. PubMed ID: 26999210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravesical treatment of bladder pain syndrome/interstitial cystitis: from the conventional regimens to the novel botulinum toxin injections.
    Dellis A; Papatsoris AG
    Expert Opin Investig Drugs; 2014 Jun; 23(6):751-7. PubMed ID: 24749738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposome-Encapsulated Botulinum Toxin A in Treatment of Functional Bladder Disorders.
    Hung FC; Kuo HC
    Toxins (Basel); 2022 Dec; 14(12):. PubMed ID: 36548734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Instillation of liposomes vs dimethyl sulphoxide or pentosan polysulphate for reducing bladder hyperactivity.
    Tyagi P; Hsieh VC; Yoshimura N; Kaufman J; Chancellor MB
    BJU Int; 2009 Dec; 104(11):1689-92. PubMed ID: 19594739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in intravesical therapy for bladder pain syndrome (BPS)/interstitial cystitis (IC).
    Meng E; Hsu YC; Chuang YC
    Low Urin Tract Symptoms; 2018 Jan; 10(1):3-11. PubMed ID: 29341502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravesical drug delivery for dysfunctional bladder.
    Hsu CC; Chuang YC; Chancellor MB
    Int J Urol; 2013 Jun; 20(6):552-62. PubMed ID: 23336527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bladder instillation of liposome encapsulated onabotulinumtoxina improves overactive bladder symptoms: a prospective, multicenter, double-blind, randomized trial.
    Chuang YC; Kaufmann JH; Chancellor DD; Chancellor MB; Kuo HC
    J Urol; 2014 Dec; 192(6):1743-9. PubMed ID: 25046622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent developments of intravesical therapy of painful bladder syndrome/interstitial cystitis: a review.
    Toft BR; Nordling J
    Curr Opin Urol; 2006 Jul; 16(4):268-72. PubMed ID: 16770126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravesical liposome administration--a novel treatment for hyperactive bladder in the rat.
    Fraser MO; Chuang YC; Tyagi P; Yokoyama T; Yoshimura N; Huang L; De Groat WC; Chancellor MB
    Urology; 2003 Mar; 61(3):656-63. PubMed ID: 12639679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin injections for adults with overactive bladder syndrome.
    Duthie J; Wilson DI; Herbison GP; Wilson D
    Cochrane Database Syst Rev; 2007 Jul; (3):CD005493. PubMed ID: 17636801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposome Based Intravesical Therapy Targeting Nerve Growth Factor Ameliorates Bladder Hypersensitivity in Rats with Experimental Colitis.
    Kawamorita N; Yoshikawa S; Kashyap M; Tyagi P; Arai Y; Chancellor MB; Yoshimura N
    J Urol; 2016 Jun; 195(6):1920-6. PubMed ID: 26780168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum Toxin A for Bladder Pain Syndrome/Interstitial Cystitis.
    Chiu B; Tai HC; Chung SD; Birder LA
    Toxins (Basel); 2016 Jul; 8(7):. PubMed ID: 27376330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of Cleaved Synaptosomal-Associated Protein-25 and Decrease of Purinergic Receptors P2X3 in the Bladder Urothelium Influence Efficacy of Botulinum Toxin Treatment for Overactive Bladder Syndrome.
    Liu HT; Chen SH; Chancellor MB; Kuo HC
    PLoS One; 2015; 10(8):e0134803. PubMed ID: 26241848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.